Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

Share Price Information for Pressure Tech (PRES)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.00
Ask: 42.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.00%)
Open: 41.00
High: 41.00
Low: 41.00
Prev. Close: 41.00
PRES Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First injection of Biomethane into National Grid

5 Oct 2010 13:00

RNS Number : 8696T
Pressure Technologies PLC
05 October 2010
 



First injection of Biomethane into UK National Grid

 

Pressure Technologies plc is pleased to announce that its subsidiary, Chesterfield BioGas ("CBG"), successfully completed its first biogas upgrading project when, earlier today, injection of organically produced gas was made directly into the National Gas Grid (the "Grid") at Thames Water's site in Didcot, Oxfordshire. This achievement is a first for the UK energy industry and the success of the Didcot site will be monitored closely.

 

The gas being injected to the Grid is produced from dirty biogas generated in the waste water treatment process at Didcot. This gas is upgraded to 97% pure methane ("biomethane"), using equipment supplied and installed by CBG.

 

CBG has the UK licence to provide a proven biogas water scrubbing technology, developed over the past 20 years by Greenlane Biogas, based in New Zealand. This technology is successfully being used in Japan, Korea, Germany, Spain, France and, predominantly, Sweden, which has pioneered the use of biomethane as a vehicle fuel and alternative to fossil fuel gas.

 

The gas produced by Thames Water is being injected in to the Grid, owned by Scotia Gas Network, and is being purchased by Centrica for sale to its domestic users.

 

Energy and Climate Change Secretary, Chris Huhne, said in a statement today: "This is an historic day for the companies involved, for energy from waste technologies and for progress to increase the amount of renewable energy in the UK."

 

Research published by National Grid shows that if all potential sources of biogas were collected and processed using anaerobic digestion and biogas upgrading, it could fulfil almost 50% of the UK's domestic gas requirement. This would contribute significantly to a reduction in greenhouse gases and guarantee security of supply by reducing the volume of imported gas usage.

 

Adoption of this type of technology in the UK has been hampered by the distortion of subsidies for electricity generation in Combined Heat and Power ("CHP") plants. The introduction of the Renewable Heat Incentive ("RHI") in 2010 has gone someway to rebalancing this disparity. A further review of the RHI, due to be published later this month, is expected to improve the balance further. As a result of this and the successful project at Didcot, Pressure Technologies hopes to see significant growth in the CBG business, which supplies upgrading systems, biomethane to grid packages and compressed natural gas refuelling stations.

 

John Hayward, Chief Executive of Pressure Technologies, said: "This is a defining moment for the UK energy market and I am tremendously proud of the role Pressure Technologies has played in the project. The persistence and dedication of our biogas team was crucial to rapid completion of this project and to making Didcot the first successful biomethane gas to grid plant in the UK."

 

For further information, please contact:

 

Pressure Technologies plc

John Hayward

 

 

Tel: 0114 242 7500

john.hayward@pressuretechnologies.co.uk

www.pressuretechnologies.co.uk

 

Fairfax I.S. PLC

Ewan Leggat/Simon Bennett/Laura Littley

 

Tel: 0207 598 5368

Rawlings Financial PR Limited

Catriona Valentine

 

Tel: 01653 618 016

catriona@rawlingsfinancial.co.uk

www.rawlingsfinancial.co.uk

 

 

Company description:

 

Pressure Technologies is the holding company for Chesterfield Special Cylinders Limited ("CSC"). CSC designs, manufactures and offers retesting and refurbishment services for a range of speciality high-pressure, seamless steel gas cylinders for global energy and defence markets. The business has been conducted under the "Chesterfield" brand which is a long established name in the cylinders and specialised pressure vessel market.

 

Chesterfield BioGas ("CBG"), an operating division of Pressure Technologies, formed in November 2008 following the signing of a co-operation agreement with Greenlane Biogas Limited, the world leader in biogas upgrading from raw biogas to vehicle quality fuel, gives Pressure Technologies exclusive rights to market Greenlane equipment in the UK and Eire. Chesterfield BioGas will provide turnkey solutions for the cleaning, storage and dispensing of biomethane, produced from waste water treatment and anaerobic digestion of organic waste.

 

Al-Met Limited ("Al-Met"), which was acquired by the Group in February 2010, is a niche manufacturer of specialised, precision engineered valve wear parts used in the oil and gas industries, based in Pontyclun, near Cardiff. Al-Met's products are used in high-pressure choke and flow control valves, designed to regulate flow volumes in extremely demanding applications in the subsea and surface oil and gas industries. The business, established in 1985, has developed a leading edge capability in precision machining carbides and superalloy matrix materials. The ability to combine high alloy steels with tungsten carbide inserts and specialised coatings gives Al-Met its niche position with its customers, global wellhead and subsea equipment OEMs.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUGGRWUUPUUBA
Date   Source Headline
27th Nov 20147:00 amRNSNotice of Preliminary Results
30th Oct 20147:00 amRNSIssue of Equity
20th Oct 20143:18 pmRNSHolding(s) in Company
17th Oct 20141:33 pmRNSIssue of Equity
1st Oct 20147:01 amRNSAcquisition of Quadscot Holdings Limited
1st Oct 20147:00 amRNSNew Bank Facilities
18th Sep 20147:00 amRNSAcquisition
1st Sep 201411:45 amRNSIssue of Equity
1st Aug 201411:25 amRNSGrant of Share Options
31st Jul 20148:00 amRNSTotal Voting Rights
21st Jul 20145:03 pmRNSDirector/PDMR Shareholding
11th Jul 201412:43 pmRNSAcquisition of shares by a Director
10th Jun 20147:00 amRNSHalf Yearly Report
30th May 20147:00 amRNSTotal Voting Rights
27th May 20147:00 amRNSNotice of Results
19th May 20147:00 amRNSIssue of Equity
4th Apr 20147:00 amRNSGrant of Share Options
31st Mar 20149:00 amRNSTotal Voting Rights
28th Mar 20149:47 amRNSHolding(s) in Company
12th Mar 20147:00 amRNSHolding(s) in Company
7th Mar 20141:10 pmRNSHolding(s) in Company
7th Mar 201412:04 pmRNSHolding(s) in Company
5th Mar 20147:00 amRNSAcquisition & Placing
13th Feb 20141:10 pmRNSResult of AGM
13th Feb 20147:00 amRNSAGM Statement
21st Jan 20147:00 amRNSContract win for Chesterfield BioGas
23rd Dec 20138:00 amRNSAnnual Financial Report
13th Dec 20137:00 amRNSStrategic Investment
3rd Dec 20137:00 amRNSPreliminary Results 2013
20th Nov 20138:00 amRNSAnalyst Briefing
23rd Oct 20137:00 amRNSNotice of Results and Trading Update
21st Aug 20137:00 amRNSContract wins for Chesterfield BioGas
20th Aug 201312:35 pmRNSHolding(s) in Company
9th Aug 201312:59 pmRNSDirector/PDMR Shareholding
9th Aug 201312:09 pmRNSGrant of Share Options
5th Aug 201312:26 pmRNSHolding(s) in Company
30th Jul 20137:00 amRNSGrant of Share Options
22nd Jul 201310:32 amRNSDirector/PDMR Shareholding
1st Jul 20135:29 pmRNSHolding(s) in Company
19th Jun 20132:13 pmRNSHolding(s) in Company
11th Jun 20137:02 amRNSBoard Appointment
11th Jun 20137:00 amRNSHalf Yearly Report
23rd May 201312:01 pmRNSNotice of Results and Analyst Briefing
18th Feb 20134:36 pmRNSHolding(s) in Company
14th Feb 20132:42 pmRNSHolding(s) in Company
12th Feb 201312:03 pmRNSResult of AGM
12th Feb 201310:12 amRNSBoard Changes
12th Feb 20137:00 amRNSTrading Update
7th Feb 201312:49 pmRNSHolding(s) in Company
1st Feb 20133:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.